Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
50,071,494
-
Shares change
-
-1,067,406
-
Total reported value, excl. options
-
$2,654,975,021
-
Value change
-
-$88,986,284
-
Put/Call ratio
-
24%
-
Number of buys
-
124
-
Number of sells
-
116
-
Price
-
$53.04
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q4 2021
As of 31 Dec 2021 HAEMONETICS CORP - Common Stock (HAE) had 313 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 50,071,494 shares of stock of the company.
Largest 10 holders included BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Neuberger Berman Group LLC, Capital Research Global Investors, STATE STREET CORP, FRANKLIN RESOURCES INC, WESTFIELD CAPITAL MANAGEMENT CO LP, LGT CAPITAL PARTNERS LTD., and Fisher Asset Management, LLC.
This table shows 313 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.